Bio
Katja Weinacht received her MD degree from Technische Universitaet Muenchen School of Medicine in 2002 and her PhD in medicine also from Technische Universitaet Muenchen in 2004. She was a postdoctoral fellow in the Channing Laboratory at Brigham and Women’s Hospital, Harvard Medical School and completaed her residency in pediatrics, at Massachusetts General Hospital, Harvard Medical School in 2009. She held a clinical pediatric fellowship in hematology/oncology at Boston Children’s Hospital, Dana-Farber Cancer Institute, Harvard Medical School from 2009-2012. Concurently, she held a research fellowship in pediatric immunology in the laboratory of Dr. Luigi D. Notarangelo at Boston Children’s Hospital, Harvard Medical School, from 2010-2012 where she acquired skills in the field of reprogramming, tissue engineering and gene correction. In 2016 she joined the pediatric faculty at Stanford University.
Her special interest in the niche of diseases that intersect immune dysfunction and primary immunodeficiency. Her clinical practice focuses on pediatric patients requiring a hematopoietic stem cell transplantation, patients with DiGeorge Syndrome and patients with genetic immune diseases presenting with autoimmunity. As a physician-scientist, she strives to advance our insights into the mechanisms leading to immunodeficiency, autoimmunity and tolerance on a molecular level and to translates her research into novel targeted therapies patients.